Clinical Trial Update: Safety Study of Nexvax2 in Subjects With Coeliac Disease [Phase 1]

View source ↗

Summary

A completed Phase 1 safety trial of Nexvax2 in individuals with celiac disease. The trial status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• Nexvax2

Snippet

Sponsor: Nexpep Pty Ltd | Conditions: Coeliac Disease, Celiac Disease | Phase 1 | Status: COMPLETED